News
On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...
As the medical device industry transitions to a highly consumer-driven marketplace, incorporating user feedback into new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback